Founded in 2014 by Dr. Pratim Sengupta in Kolkata, Nephro Care India Limited provides comprehensive medical services for renal patients. It serves as a one-stop treatment center offering a wide range of clinical and lifestyle solutions for renal insufficiency. Nephro Care's framework addresses lifestyle, physiological, and spiritual aspects of wellness, supported by expert doctors, well-trained paramedical professionals, and a skilled management team.
The company's main clinic is located in Salt Lake City, Kolkata, with a leased facility offering services such as in-house dialysis, outpatient care in nephrology, diabetology, cardiology, ophthalmology, and neurology, NABL accredited pathology, a pharmacy, advanced diagnostic facilities, and home care. Additionally, Nephro Care operates a clinic in Chandernagore and a dialysis unit in Salt Lake City, Kolkata.
Nephro Care's vision is to reach a million kidney disease patients across India through a hub-and-spoke model, combining modern medicine with traditional yogic wisdom. The clinics are equipped with advanced diagnostic instruments, ensuring comprehensive care under one roof and optimum clinical outcomes.
Currently, Nephro Care serves around 900 Chronic Kidney Disease (CKD) patients monthly, with a dedicated team of permanent doctors, visiting consultants, and paramedical professionals. Plans are underway to convert a 60-bed hospital in Madhyamgram, Kolkata, into a 100-bed multi-specialty hospital, funded partly by IPO proceeds. Additionally, new satellite clinics are being established in Alipurduar, Shyambazar, and Balasore.
Nephro Care has received the "Power Icon" award from the Times of India Group for its contributions to healthcare in Eastern India. The company's services include in-house dialysis, outpatient services, pathology, pharmacy, advanced diagnostics, renal nutrition, home care, lifestyle support programs, and home dialysis.
Nephro Care's strong technology backbone and in-house innovations, like the portable RO system for home dialysis, enhance the quality and efficiency of its services. The company's digital applications, such as the Hospital Information System and Electronic Medical Records, ensure seamless patient care and operational efficiency.
Industry Outlook:
- With 10% of the global population affected by CKD (Chronic Kidney Disease) and an increasing number of cases in India, the demand for kidney disease treatment is set to grow significantly.
- India's robust economic growth and substantial investments in the healthcare sector provide a fertile ground for expanding medical services and infrastructure.
- Government programs like Ayushman Bharat are improving healthcare accessibility and affordability, creating opportunities for Nephro Care India Limited to serve a broader demographic and drive growth.
Nephro Care India Limited IPO Objectives
The company plans to allocate the net proceeds from the issuance to the following purposes:
- Setting up a new hospital named "Vivacity Multi-Speciality Hospital" (a unit of Nephro Care) in Kolkata (Madhyamgaram), West Bengal.
- Covering general corporate expenses to support business growth and operations.
Peer Details
According to the DRHP, there are no listed companies in India that operate in a business similar to Nephro Care India Limited.
How to Check the Allotment Status of the Nephro Care India Limited IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app
- Go to the individual order details page of the IPO that you had applied for.
- Check the IPO allotment status. As such, Angel One will notify you of your IPO allotment status via push notification, email, and SMS.
Contact Details of Nephro Care India Limited IPO
- Registered office: Flat No-1JC-18, 5th Floor Sec-III, Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098 West Bengal, India
- Phone: +91 8017010197
- E-mail:cs@nephrocareindia.com
IPO Financials
| Particulars | Year ended December 31, 2023 | Year ending on 31st March 2023 | Year ending on 31st March 2022 |
|---|---|---|---|
| Revenue from Operations (in ₹ lakh) | 1,975.14 | 1,709.27 | 342.44 |
| Profit After Tax (PAT) (in ₹ lakh) | 340.04 | 194.24 | (0.98) |
| Cash & Cash Equivalents (in ₹ lakh) | 215.69 | 231.66 | 60.90 |
| Return on Net Worth (%) | 24.42 | 79.68 | (1.98) |
| Earnings per share | 3.36 | 1.94 | (0.03) |
| EBITDA(in ₹ lakh) | 504.64 | 364.53 | 12.56 |
| Return On Capital Employed (%) | 36.56 | 71.09 | 4.13 |
Know before investing
Strengths
6Comprehensive home care services enhancing patient convenience.
Robust technology infrastructure for enhanced operational efficiency.
Nationally recognised leadership driving clinical excellence.
High patient satisfaction through personalized healthcare solutions.
Expansion plans to establish multi-specialty hospitals for broader service offerings.
Strategic alliances with leading medical institutions for research and development.
Risks
6Dependency on Dr. Pratim Sengupta risks operational stability if he leaves.
Lack of experience in multispecialty hospitals poses financial and operational risks.
Heavy reliance on revenue from Salt Lake clinic exposes local risks.
Attrition among healthcare professionals could impact service quality and patient care.
Regulatory compliance issues may lead to operational disruptions or license loss.
Rising costs of manpower and medical supplies threaten profitability and operational efficiency.
